Breast cancer morbidity: Questionnaire survey of patients on the long term effects of disease and adjuvant therapy;Morbidität nach Brustkrebs: Befragung von Mammakarzinom-Patientinnen zu den Langzeitfolgen von Erkrankung, operativer und adjuvanter Therapie

Deutsches Arzteblatt International

Volumn 111, Issue 31-32, 2014, Pages 537-544

  Feiten, Stefan ^a   Dünnebacke, Jan ^b   Heymanns, Jochen ^c   Köppler, Hubert ^c   Thomalla, Jörg ^c   Van Roye, Christoph ^c   Wey, Diana ^b   Weide, Rudolf ^c  

^a Institut fur Versorgungsforschung in der Onkologie   (Germany)

^b Katholisches Klinikum Koblenz   (Germany)

^c Praxisklinik fur Hamatologie und Onkologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT; TAMOXIFEN;

ADULT; AGED; ARM MOVEMENT; ARM SWELLING; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG WITHDRAWAL; EMPLOYMENT; FEMALE; FUNCTIONAL DISEASE; GROUPS BY AGE; HEALTH CARE SURVEY; HOSPITALIZATION; HUMAN; JOINT LIMITATION; LONG TERM CARE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MORBIDITY; OUTCOME ASSESSMENT; PAIN; PARTIAL MASTECTOMY; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PSYCHIATRIST; PSYCHOTHERAPIST; PSYCHOTHERAPY; QUESTIONNAIRE; SOCIAL INTERACTION; SYSTEMIC THERAPY; TELEPHONE INTERVIEW; ADJUVANT CHEMORADIOTHERAPY; BREAST NEOPLASMS; CLINICAL TRIAL; GERMANY; LONGITUDINAL STUDY; MASTECTOMY; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; GERMANY; HEALTH CARE SURVEYS; HUMANS; LONGITUDINAL STUDIES; MASTECTOMY; MENTAL DISORDERS; MIDDLE AGED; PATIENT SATISFACTION; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84907466694     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2014.0537     Document Type: Article

References (35)

1. Siegel R, DeSantis C, Virgo K, et al.: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-41.
2. Montazeri A: Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008; 27: 32.
3. Kornblith AB, Ligibel J: Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol 2003; 30: 799-813.
4. Partridge AH, Burstein HJ, Winer EP: Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr 2001; 30: 135-42.
5. Azim HA Jr, de Azambuja E, Colozza M, Bines J, Piccart MJ: Longterm toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol 2011; 22: 1939-47.
6. Schaapveld M, Visser O, Louwman MJ, et al.: Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol 2008; 26: 1239-46.
7. DiSipio T, Rye S, Newman B, Hayes S: Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013; 14: 500-15.
8. Janni W, Kühn T, Schwentner L, Kreienberg R, Fehm T, Wöckel A: Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits. Dtsch Arztebl Int 2014; 111: 244-9.
9. Schlitt A, Jordan K, Vordermark D, Schwamborn J, Langer T, Thomssen C: Cardiotoxicity and oncological treatments. Dtsch Arzt-ebl Int 2014; 111: 161-8.
10. Tannock I F, Ahles TA, Ganz PA, Van Dam FS: Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 2004; 22: 2233-9.
11. Mitchell AJ, Chan M, Bhatti H, et al.: Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160-74.
12. Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P: Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 2013; 14: 721-32.
13. Gao J, Dizon DS: Preparing for survivorship: quality of life in breast cancer survivors. J Sex Med 2013; 10: 16-20.
14. Faul F, Erdfelder E, Lang A-G, Buchner A: G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007; 39: 175-91.
15. Duric VM, Butow PN, Sharpe L, et al.: Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psychooncology 2007; 16: 48-59.
16. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Kurzversion 3.0. www.awmf.org/leitlinien/detail/ ll/032-045OL.html (last accessed on 18 May 2014).
17. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE: Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998; 16: 501-14.
18. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998; 16: 1689-96.
19. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J: Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18: 1437-49.
20. Thomas-MacLean R, Miedema B, Tatemichi SR: Breast cancer-related lymphedema: women's experiences with an underestimated condition. Can Fam Physician 2005; 51: 246-7.
21. Ridner SH, Sinclair V, Deng J, Bonner CM, Kidd N, Dietrich MS: Breast cancer survivors with lymphedema: glimpses of their daily lives. Clin J Oncol Nurs 2012; 16: 609-14.
22. Sweeney C, Schmitz KH, Lazovich D, Virnig BA, Wallace RB, Folsom AR: Functional limitations in elderly female cancer survivors. J Natl Cancer Inst 2006; 98: 521-9.
23. Tsai RJ, Dennis LK, Lynch C F, Snetselaar LG, Zamba GK, Scott-Conner C: The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 2009; 16: 1959-72.
24. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D: Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J 2004; 10: 223-31.
25. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E: A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006; 20: 76-89.
26. Morse R, Rodgers J, Verrill M, Kendell K: Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review. Eur J Cancer 2003; 39: 2288-97.
27. Tchen N, Juffs HG, Downie F P, et al.: Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003; 21: 4175-83.
28. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF: Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000; 18: 2695-701.
29. Vardy J, Wefel JS, Ahles T, Tannock I F, Schagen SB: Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008; 19: 623-9.
30. Minisini A, Atalay G, Bottomley A, Puglisi F, Piccart M, Biganzoli L: What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 2004; 5: 273-82.
31. Ahles TA, Saykin AJ: Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 2002; 3: 84-90.
32. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA: Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 2007; 25: 3866-70.
33. Fann JR, Thomas-Rich AM, Katon WJ, et al.: Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 2008; 30: 112-26.
34. Gilbert E, Ussher JM, Perz J: Sexuality after breast cancer: a review. Maturitas 2010; 66: 397-407.
35. Bober SL, Giobbie-Hurder A, Emmons KM, Winer E, Partridge A: Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ. J Sex Med 2013; 10: 370-7.